{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:04Z","timestamp":1794330244425,"version":"4.9.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12325-025-03185-9","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T08:30:09Z","timestamp":1745051409000},"page":"2659-2678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments"],"prefix":"10.1007","volume":"42","author":[{"given":"Kazi","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahib","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humza","family":"Pirzadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barsha","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella B.","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4545-4523","authenticated-orcid":false,"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"3185_CR1","unstructured":"Sapra A, Bhandari P. Diabetes. In: StatPearls. Treasure Island: StatPearls Publishing; 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560927\/."},{"key":"3185_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","volume":"17","author":"C Rask-Madsen","year":"2013","unstructured":"Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17:20\u201333. https:\/\/doi.org\/10.1016\/j.cmet.2012.11.012.","journal-title":"Cell Metab"},{"key":"3185_CR3","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","volume":"34","author":"F Paneni","year":"2013","unstructured":"Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436\u201343. https:\/\/doi.org\/10.1093\/eurheartj\/eht149.","journal-title":"Eur Heart J"},{"key":"3185_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1359255","author":"D-R Yang","year":"2024","unstructured":"Yang D-R, Wang M-Y, Zhang C-L, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol. 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1359255.","journal-title":"Front Endocrinol"},{"key":"3185_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13167-023-00314-8","volume":"14","author":"M Kropp","year":"2023","unstructured":"Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T-TKS, de Clerck E, Polivka J, Potuznik P, Polivka J, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023;14:21\u201342. https:\/\/doi.org\/10.1007\/s13167-023-00314-8.","journal-title":"EPMA J"},{"issue":"12","key":"3185_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"2022","author":"CP Kovesdy","year":"2011","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2011;2022(12):7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003.","journal-title":"Kidney Int Suppl"},{"key":"3185_CR7","unstructured":"Molina CS, Faulk JB. Lower extremity amputation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546594\/."},{"key":"3185_CR8","doi-asserted-by":"publisher","first-page":"1088882","DOI":"10.3389\/fendo.2023.1088882","volume":"14","author":"L Fang","year":"2023","unstructured":"Fang L, Sheng H, Tan Y, Zhang Q. Prevalence of diabetes in the USA from the perspective of demographic characteristics, physical indicators and living habits based on NHANES 2009\u20132018. Front Endocrinol (Lausanne). 2023;14:1088882. https:\/\/doi.org\/10.3389\/fendo.2023.1088882.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3185_CR9","unstructured":"CDC National Diabetes Statistics Report. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html. Accessed 30 May 2024."},{"key":"3185_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"3185_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","volume":"47","author":"ED Parker","year":"2024","unstructured":"Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, ElSayed NA, Bannuru RR. Economic costs of diabetes in the US in 2022. Diabetes Care. 2024;47:26\u201343. https:\/\/doi.org\/10.2337\/dci23-0085.","journal-title":"Diabetes Care"},{"key":"3185_CR12","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1001\/jama.2017.19546","volume":"318","author":"MP Bancks","year":"2017","unstructured":"Bancks MP, Kershaw K, Carson AP, Gordon-Larsen P, Schreiner PJ, Carnethon MR. Association of modifiable risk factors in young adulthood with racial disparity in incident type 2 diabetes during middle adulthood. JAMA. 2017;318:2457\u201365. https:\/\/doi.org\/10.1001\/jama.2017.19546.","journal-title":"JAMA"},{"key":"3185_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2021.12531","volume":"326","author":"US Preventive Services Task Force","year":"2021","unstructured":"US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement. JAMA. 2021;326:736\u201343. https:\/\/doi.org\/10.1001\/jama.2021.12531.","journal-title":"JAMA"},{"key":"3185_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","volume":"44","author":"F Hill-Briggs","year":"2021","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, Thornton PL, Haire-Joshu D. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2021;44:258\u201379. https:\/\/doi.org\/10.2337\/dci20-0053.","journal-title":"Diabetes Care"},{"key":"3185_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1056\/NEJM199007053230106","volume":"323","author":"FH Epstein","year":"1990","unstructured":"Epstein FH, Vane JR, \u00c4ngg\u00e5rd EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27\u201336. https:\/\/doi.org\/10.1056\/NEJM199007053230106.","journal-title":"N Engl J Med"},{"key":"3185_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924\u201367. https:\/\/doi.org\/10.1124\/pharmrev.120.000096.","journal-title":"Pharmacol Rev"},{"key":"3185_CR17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/antiox10081306","volume":"10","author":"T Maruhashi","year":"2021","unstructured":"Maruhashi T, Higashi Y. Pathophysiological association between diabetes mellitus and endothelial dysfunction. Antioxidants. 2021;10:1306. https:\/\/doi.org\/10.3390\/antiox10081306.","journal-title":"Antioxidants"},{"key":"3185_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","volume":"20","author":"T Yuan","year":"2019","unstructured":"Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, Yuan Q, Yu H, Xu W, Xie X. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019;20:247\u201360. https:\/\/doi.org\/10.1016\/j.redox.2018.09.025.","journal-title":"Redox Biol"},{"key":"3185_CR19","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97:2499\u2013574. https:\/\/doi.org\/10.1007\/s00204-023-03562-9.","journal-title":"Arch Toxicol"},{"key":"3185_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U F\u00f6rstermann","year":"2017","unstructured":"F\u00f6rstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120:713\u201335. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309326.","journal-title":"Circ Res"},{"key":"3185_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/biology10010018","volume":"10","author":"A Charlton","year":"2020","unstructured":"Charlton A, Garzarella J, Jandeleit-Dahm KAM, Jha JC. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology. 2020;10:18. https:\/\/doi.org\/10.3390\/biology10010018.","journal-title":"Biology"},{"key":"3185_CR22","doi-asserted-by":"publisher","first-page":"e45835","DOI":"10.7759\/cureus.45835","volume":"15","author":"M Zakir","year":"2023","unstructured":"Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, Kashif M, Shahzeen F, Tayyab A, Khan MSM, et al. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023;15:e45835. https:\/\/doi.org\/10.7759\/cureus.45835.","journal-title":"Cureus"},{"issue":"2 Suppl 1","key":"3185_CR23","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/j.dsx.2016.03.016","volume":"10","author":"A Berezin","year":"2016","unstructured":"Berezin A. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S176\u2013S183. https:\/\/doi.org\/10.1016\/j.dsx.2016.03.016.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"3185_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11892-013-0371-2","volume":"13","author":"C Bianchi","year":"2013","unstructured":"Bianchi C, Miccoli R, Del Prato S. Hyperglycemia and vascular metabolic memory: truth or fiction?. Curr Diab Rep. 2013;13(3):403\u2013410. https:\/\/doi.org\/10.1007\/s11892-013-0371-2.","journal-title":"Curr Diab Rep"},{"key":"3185_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biom12040542","volume":"12","author":"M Khalid","year":"2022","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12:542. https:\/\/doi.org\/10.3390\/biom12040542.","journal-title":"Biomolecules"},{"key":"3185_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-01755-x","volume":"9","author":"H Dong","year":"2024","unstructured":"Dong H, Sun Y, Nie L, Cui A, Zhao P, Leung WK, Wang Q. Metabolic memory: mechanisms and diseases. Signal Transduct Target Ther. 2024;9:38. https:\/\/doi.org\/10.1038\/s41392-024-01755-x.","journal-title":"Signal Transduct Target Ther"},{"key":"3185_CR27","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/antiox11101958","volume":"11","author":"Y Higashi","year":"2022","unstructured":"Higashi Y. Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease. Antioxidants (Basel). 2022;11:1958. https:\/\/doi.org\/10.3390\/antiox11101958.","journal-title":"Antioxidants (Basel)"},{"key":"3185_CR28","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","volume":"10","author":"F Zatterale","year":"2020","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, Beguinot F. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020;10:1607. https:\/\/doi.org\/10.3389\/fphys.2019.01607.","journal-title":"Front Physiol"},{"key":"3185_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2019.112578","volume":"208","author":"MC Farruggia","year":"2019","unstructured":"Farruggia MC, Small DM. Effects of adiposity and metabolic dysfunction on cognition: a review. Physiol Behav. 2019;208: 112578. https:\/\/doi.org\/10.1016\/j.physbeh.2019.112578.","journal-title":"Physiol Behav"},{"key":"3185_CR30","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.3390\/ijms21207711","volume":"21","author":"S Feij\u00f3o-Band\u00edn","year":"2020","unstructured":"Feij\u00f3o-Band\u00edn S, Arag\u00f3n-Herrera A, Mora\u00f1a-Fern\u00e1ndez S, Anido-Varela L, Taraz\u00f3n E, Rosell\u00f3-Llet\u00ed E, Portol\u00e9s M, Moscoso I, Gualillo O, Gonz\u00e1lez-Juanatey JR, et al. Adipokines and inflammation: focus on cardiovascular diseases. Int J Mol Sci. 2020;21:7711. https:\/\/doi.org\/10.3390\/ijms21207711.","journal-title":"Int J Mol Sci"},{"key":"3185_CR31","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.2174\/0929867329666220729154615","volume":"30","author":"CR Triggle","year":"2023","unstructured":"Triggle CR, Marei I, Ye K, Ding H, Anderson TJ, Hollenberg MD, Hill MA. Repurposing metformin for vascular disease. Curr Med Chem. 2023;30:3955\u201378. https:\/\/doi.org\/10.2174\/0929867329666220729154615.","journal-title":"Curr Med Chem"},{"key":"3185_CR32","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.3390\/ijms24076039","volume":"24","author":"ME Youssef","year":"2023","unstructured":"Youssef ME, Yahya G, Popoviciu MS, Cavalu S, Abd-Eldayem MA, Saber S. Unlocking the full potential of SGLT2 inhibitors: expanding applications beyond glycemic control. Int J Mol Sci. 2023;24:6039. https:\/\/doi.org\/10.3390\/ijms24076039.","journal-title":"Int J Mol Sci"},{"key":"3185_CR33","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/cells9071708","volume":"9","author":"K Duszka","year":"2020","unstructured":"Duszka K, Gregor A, Guillou H, K\u00f6nig J, Wahli W. Peroxisome proliferator-activated receptors and caloric restriction\u2014common pathways affecting metabolism, health, and longevity. Cells. 2020;9:1708. https:\/\/doi.org\/10.3390\/cells9071708.","journal-title":"Cells"},{"key":"3185_CR34","doi-asserted-by":"publisher","first-page":"e47525","DOI":"10.7759\/cureus.47525","volume":"15","author":"A Yachmaneni","year":"2023","unstructured":"Yachmaneni A, Jajoo S, Mahakalkar C, Kshirsagar S, Dhole S. A comprehensive review of the vascular consequences of diabetes in the lower extremities: current approaches to management and evaluation of clinical outcomes. Cureus. 2023;15:e47525. https:\/\/doi.org\/10.7759\/cureus.47525.","journal-title":"Cureus"},{"key":"3185_CR35","doi-asserted-by":"publisher","DOI":"10.2174\/1871527320666210825112240","volume":"18","author":"D Ziegler","year":"2022","unstructured":"Ziegler D, Porta M, Papanas N, Mota M, Jermendy G, Beltramo E, Mazzeo A, Caccioppo A, Striglia E, Serhiyenko V, et al. The role of biofactors in diabetic microvascular complications. Curr Diabetes Rev. 2022;18: e250821195830. https:\/\/doi.org\/10.2174\/1871527320666210825112240.","journal-title":"Curr Diabetes Rev"},{"key":"3185_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ecl.2021.05.005","volume":"50","author":"W Crasto","year":"2021","unstructured":"Crasto W, Patel V, Davies MJ, Khunti K. Prevention of microvascular complications of diabetes. Endocrinol Metab Clin North Am. 2021;50:431\u201355. https:\/\/doi.org\/10.1016\/j.ecl.2021.05.005.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"3185_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, Huang L, Liu Y. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther. 2023;8:152. https:\/\/doi.org\/10.1038\/s41392-023-01400-z.","journal-title":"Signal Transduct Target Ther"},{"key":"3185_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107613","volume":"34","author":"S Paul","year":"2020","unstructured":"Paul S, Ali A, Katare R. Molecular complexities underlying the vascular complications of diabetes mellitus\u2014a comprehensive review. J Diabetes Complications. 2020;34: 107613. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107613.","journal-title":"J Diabetes Complications"},{"key":"3185_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20050025","volume":"109","author":"CG Schalkwijk","year":"2005","unstructured":"Schalkwijk CG, Stehouwer CDA. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109:143\u201359. https:\/\/doi.org\/10.1042\/CS20050025.","journal-title":"Clin Sci (Lond)"},{"key":"3185_CR40","doi-asserted-by":"publisher","first-page":"1380929","DOI":"10.3389\/fendo.2024.1380929","volume":"15","author":"A Atmaca","year":"2024","unstructured":"Atmaca A, Ketenci A, Sahin I, Sengun IS, Oner RI, Erdem Tilki H, Adas M, Soyleli H, Demir T. Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach. Front Endocrinol (Lausanne). 2024;15:1380929. https:\/\/doi.org\/10.3389\/fendo.2024.1380929.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3185_CR41","doi-asserted-by":"publisher","first-page":"CD010975","DOI":"10.1002\/14651858.CD010975.pub2","volume":"2018","author":"Z Yang","year":"2018","unstructured":"Yang Z, Zhang Y, Chen R, Huang Y, Ji L, Sun F, Hong T, Zhan S. Simple tests to screen for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2018;2018:CD010975. https:\/\/doi.org\/10.1002\/14651858.CD010975.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3185_CR42","unstructured":"Novello BJ, Pobre T. Electrodiagnostic evaluation of peripheral neuropathy. In: StatPearls. Treasure Island (Fl): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563169\/."},{"key":"3185_CR43","unstructured":"Bains S, Rocha Cabrero F. Electrodiagnostic evaluation of ulnar neuropathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564408\/."},{"key":"3185_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v9.i1.1","volume":"9","author":"VA Serhiyenko","year":"2018","unstructured":"Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: risk factors, diagnosis and treatment. World J Diabetes. 2018;9:1\u201324. https:\/\/doi.org\/10.4239\/wjd.v9.i1.1.","journal-title":"World J Diabetes"},{"key":"3185_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40139-020-00205-x","volume":"8","author":"RI Mota","year":"2020","unstructured":"Mota RI, Morgan SE, Bahnson EM. Diabetic vasculopathy: macro and microvascular injury. Curr Pathobiol Rep. 2020;8:1\u201314. https:\/\/doi.org\/10.1007\/s40139-020-00205-x.","journal-title":"Curr Pathobiol Rep"},{"key":"3185_CR46","doi-asserted-by":"publisher","first-page":"3448618","DOI":"10.1155\/2022\/3448618","volume":"2022","author":"J Wei","year":"2022","unstructured":"Wei J, Tian J, Tang C, Fang X, Miao R, Wu H, Wang X, Tong X. The influence of different types of diabetes on vascular complications. J Diabetes Res. 2022;2022:3448618. https:\/\/doi.org\/10.1155\/2022\/3448618.","journal-title":"J Diabetes Res"},{"key":"3185_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/nu9050437","volume":"9","author":"R Testa","year":"2017","unstructured":"Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A. The, \u201cmetabolic memory\u201d theory and the early treatment of hyperglycemia in prevention of diabetic complications. Nutrients. 2017;9:437. https:\/\/doi.org\/10.3390\/nu9050437.","journal-title":"Nutrients"},{"key":"3185_CR48","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.3949\/ccjm.84.s1.03","volume":"84","author":"JP Kirwan","year":"2017","unstructured":"Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. CCJM. 2017;84:S15\u201321. https:\/\/doi.org\/10.3949\/ccjm.84.s1.03.","journal-title":"CCJM"},{"key":"3185_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40520-018-1012-z","volume":"31","author":"J Liu","year":"2019","unstructured":"Liu J, Zhu L, Li P, Li N, Xu Y. Effectiveness of high-intensity interval training on glycemic control and cardiorespiratory fitness in patients with type 2 diabetes: a systematic review and meta-analysis. Aging Clin Exp Res. 2019;31:575\u201393. https:\/\/doi.org\/10.1007\/s40520-018-1012-z.","journal-title":"Aging Clin Exp Res"},{"key":"3185_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2337\/diaspect.28.1.39","volume":"28","author":"ME Francois","year":"2015","unstructured":"Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectr. 2015;28:39\u201344. https:\/\/doi.org\/10.2337\/diaspect.28.1.39.","journal-title":"Diabetes Spectr"},{"key":"3185_CR51","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2337\/dc16-1728","volume":"39","author":"SR Colberg","year":"2016","unstructured":"Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF. Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39:2065\u201379. https:\/\/doi.org\/10.2337\/dc16-1728.","journal-title":"Diabetes Care"},{"key":"3185_CR52","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.3390\/ijerph18137201","volume":"18","author":"MM Atakan","year":"2021","unstructured":"Atakan MM, Li Y, Ko\u015far \u015eN, Turnag\u00f6l HH, Yan X. Evidence-based effects of high-intensity interval training on exercise capacity and health: a review with historical perspective. Int J Environ Res Public Health. 2021;18:7201. https:\/\/doi.org\/10.3390\/ijerph18137201.","journal-title":"Int J Environ Res Public Health"},{"key":"3185_CR53","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.3949\/ccjm.84.s1.03","volume":"84","author":"JP Kirwan","year":"2017","unstructured":"Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017;84:S15\u201321. https:\/\/doi.org\/10.3949\/ccjm.84.s1.03.","journal-title":"Cleve Clin J Med"},{"key":"3185_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1249\/MSS.0000000000002800","volume":"54","author":"JA Kanaley","year":"2022","unstructured":"Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, Kirwan JP, Zierath JR. Exercise\/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54:353\u201368. https:\/\/doi.org\/10.1249\/MSS.0000000000002800.","journal-title":"Med Sci Sports Exerc"},{"key":"3185_CR55","unstructured":"What Is Moderate to Vigorous Exercise Intensity? PMC. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8493117\/. Accessed 3 Oct 2024."},{"key":"3185_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1559827619867693","volume":"15","author":"M Jones","year":"2019","unstructured":"Jones M, Bright P, Hansen L, Ihnatsenka O, Carek PJ. Promoting physical activity in a primary care practice: overcoming the barriers. Am J Lifestyle Med. 2019;15:158\u201364. https:\/\/doi.org\/10.1177\/1559827619867693.","journal-title":"Am J Lifestyle Med"},{"key":"3185_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4330\/wjc.v11.i7.171","volume":"11","author":"S Ito","year":"2019","unstructured":"Ito S. High-intensity interval training for health benefits and care of cardiac diseases\u2014the key to an efficient exercise protocol. World J Cardiol. 2019;11:171\u201388. https:\/\/doi.org\/10.4330\/wjc.v11.i7.171.","journal-title":"World J Cardiol"},{"key":"3185_CR58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4082\/kjfm.19.0038","volume":"40","author":"YJ Yang","year":"2019","unstructured":"Yang YJ. An overview of current physical activity recommendations in primary care. Korean J Fam Med. 2019;40:135\u201342. https:\/\/doi.org\/10.4082\/kjfm.19.0038.","journal-title":"Korean J Fam Med"},{"key":"3185_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajmo.2023.100031","volume":"9","author":"USA Syeda","year":"2023","unstructured":"Syeda USA, Battillo D, Visaria A, Malin SK. The importance of exercise for glycemic control in type 2 diabetes. Am J Med Open. 2023;9: 100031. https:\/\/doi.org\/10.1016\/j.ajmo.2023.100031.","journal-title":"Am J Med Open"},{"key":"3185_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jshs.2022.10.003","volume":"12","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Fern\u00e1ndez-Garc\u00eda B, Lehmann HI, Li G, Kroemer G, L\u00f3pez-Ot\u00edn C, Xiao J. Exercise sustains the hallmarks of health. J Sport Health Sci. 2023;12:8\u201335. https:\/\/doi.org\/10.1016\/j.jshs.2022.10.003.","journal-title":"J Sport Health Sci"},{"key":"3185_CR61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000500110","volume":"74","author":"D Yang","year":"2019","unstructured":"Yang D, Yang Y, Li Y, Han R. Physical exercise as therapy for type 2 diabetes mellitus: from mechanism to orientation. Ann Nutr Metab. 2019;74:313\u201321. https:\/\/doi.org\/10.1159\/000500110.","journal-title":"Ann Nutr Metab"},{"key":"3185_CR62","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/medicina59101882","volume":"59","author":"SA Derrick","year":"2023","unstructured":"Derrick SA, Nguyen ST, Marthens JR, Dambacher LL, Sikalidis AK, Reaves SK. A Mediterranean-style diet improves the parameters for the management and prevention of type 2 diabetes mellitus. Medicina (Kaunas). 2023;59:1882. https:\/\/doi.org\/10.3390\/medicina59101882.","journal-title":"Medicina (Kaunas)"},{"issue":"20","key":"3185_CR63","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.3760\/cma.j.issn.0366-6999.20141358","volume":"127","author":"H Khemayanto","year":"2014","unstructured":"Khemayanto H, Shi B. Role of Mediterranean diet in prevention and management of type 2 diabetes. Chin Med J (Engl). 2014;127(20):3651\u20133656.","journal-title":"Chin Med J (Engl)"},{"key":"3185_CR64","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/nu12041066","volume":"12","author":"M Mirabelli","year":"2020","unstructured":"Mirabelli M, Chiefari E, Arcidiacono B, Corigliano DM, Brunetti FS, Maggisano V, Russo D, Foti DP, Brunetti A. Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients. 2020;12:1066. https:\/\/doi.org\/10.3390\/nu12041066.","journal-title":"Nutrients"},{"key":"3185_CR65","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/advances\/nmac046","volume":"13","author":"P Sarsangi","year":"2022","unstructured":"Sarsangi P, Salehi-Abargouei A, Ebrahimpour-Koujan S, Esmaillzadeh A. Association between adherence to the Mediterranean diet and risk of type 2 diabetes: an updated systematic review and dose-response meta-analysis of prospective cohort studies. Adv Nutr. 2022;13:1787\u201398. https:\/\/doi.org\/10.1093\/advances\/nmac046.","journal-title":"Adv Nutr"},{"key":"3185_CR66","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3390\/nu13041307","volume":"13","author":"T Milenkovic","year":"2021","unstructured":"Milenkovic T, Bozhinovska N, Macut D, Bjekic-Macut J, Rahelic D, Velija Asimi Z, Burekovic A. Mediterranean diet and type 2 diabetes mellitus: a perpetual inspiration for the scientific world. A review. Nutrients. 2021;13:1307. https:\/\/doi.org\/10.3390\/nu13041307.","journal-title":"Nutrients"},{"key":"3185_CR67","doi-asserted-by":"publisher","first-page":"FSO843","DOI":"10.2144\/fsoa-2022-0058","volume":"9","author":"S Sabarathinam","year":"2023","unstructured":"Sabarathinam S. A glycemic diet improves the understanding of glycemic control in diabetes patients during their follow-up. Future Sci OA. 2023;9:FSO843. https:\/\/doi.org\/10.2144\/fsoa-2022-0058.","journal-title":"Future Sci OA"},{"key":"3185_CR68","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/nu2121266","volume":"2","author":"JM Lattimer","year":"2010","unstructured":"Lattimer JM, Haub MD. Effects of dietary fiber and its components on metabolic health. Nutrients. 2010;2:1266\u201389. https:\/\/doi.org\/10.3390\/nu2121266.","journal-title":"Nutrients"},{"key":"3185_CR69","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1017\/S1368980024000776","volume":"27","author":"Z Cai","year":"2024","unstructured":"Cai Z, Wang L, Zhang B, Zhu A. Mediterranean diet for cardiovascular disease: an evidence mapping study. Public Health Nutr. 2024;27:e118. https:\/\/doi.org\/10.1017\/S1368980024000776.","journal-title":"Public Health Nutr"},{"key":"3185_CR70","doi-asserted-by":"publisher","first-page":"e43882","DOI":"10.7759\/cureus.43882","volume":"15","author":"F Jyotsna","year":"2023","unstructured":"Jyotsna F, Ahmed A, Kumar K, Kaur P, Chaudhary MH, Kumar S, Khan E, Khanam B, Shah SU, Varrassi G, et al. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus. 2023;15:e43882. https:\/\/doi.org\/10.7759\/cureus.43882.","journal-title":"Cureus"},{"key":"3185_CR71","volume-title":"Endotext","author":"A Reynolds","year":"2000","unstructured":"Reynolds A, Mitri J. Dietary advice for individuals with diabetes. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferr\u00e8re B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext. South Dartmouth: MDText.com, Inc.; 2000."},{"key":"3185_CR72","unstructured":"Associations between timing and duration of eating and glucose metabolism: a nationally representative study in the US-PMC. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9919634\/. Accessed 6 Aug 2024."},{"key":"3185_CR73","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3390\/nu7075266","volume":"7","author":"B Troesch","year":"2015","unstructured":"Troesch B, Biesalski HK, Bos R, Buskens E, Calder PC, Saris WHM, Spieldenner J, Verkade HJ, Weber P, Eggersdorfer M. Increased intake of foods with high nutrient density can help to break the intergenerational cycle of malnutrition and obesity. Nutrients. 2015;7:6016\u201337. https:\/\/doi.org\/10.3390\/nu7075266.","journal-title":"Nutrients"},{"key":"3185_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-nutr-121415-112624","volume":"36","author":"AL Carreiro","year":"2016","unstructured":"Carreiro AL, Dhillon J, Gordon S, Jacobs AG, Higgins KA, McArthur BM, Redan BW, Rivera RL, Schmidt LR, Mattes RD. The macronutrients, appetite and energy intake. Annu Rev Nutr. 2016;36:73\u2013103. https:\/\/doi.org\/10.1146\/annurev-nutr-121415-112624.","journal-title":"Annu Rev Nutr"},{"key":"3185_CR75","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1475-2891-11-98","volume":"11","author":"MC Klempel","year":"2012","unstructured":"Klempel MC, Kroeger CM, Bhutani S, Trepanowski JF, Varady KA. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J. 2012;11:98. https:\/\/doi.org\/10.1186\/1475-2891-11-98.","journal-title":"Nutr J"},{"key":"3185_CR76","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2174\/157016111795495558","volume":"9","author":"DM Breen","year":"2011","unstructured":"Breen DM, Giacca A. Effects of insulin on the vasculature. Curr Vasc Pharmacol. 2011;9:321\u201332. https:\/\/doi.org\/10.2174\/157016111795495558.","journal-title":"Curr Vasc Pharmacol"},{"key":"3185_CR77","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/nu11040873","volume":"11","author":"MM Grajower","year":"2019","unstructured":"Grajower MM, Horne BD. Clinical management of intermittent fasting in patients with diabetes mellitus. Nutrients. 2019;11:873. https:\/\/doi.org\/10.3390\/nu11040873.","journal-title":"Nutrients"},{"key":"3185_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11892-017-0951-7","volume":"17","author":"S Golbidi","year":"2017","unstructured":"Golbidi S, Daiber A, Korac B, Li H, Essop MF, Laher I. Health benefits of fasting and caloric restriction. Curr Diab Rep. 2017;17:123. https:\/\/doi.org\/10.1007\/s11892-017-0951-7.","journal-title":"Curr Diab Rep"},{"issue":"2","key":"3185_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.diabres.2010.04.019","volume":"89","author":"K Esposito","year":"2010","unstructured":"Esposito K, Maiorino MI, Ceriello A, Giugliano D. Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract. 2010;89(2):97\u2013102. https:\/\/doi.org\/10.1016\/j.diabres.2010.04.019.","journal-title":"Diabetes Res Clin Pract"},{"key":"3185_CR80","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/nu14030631","volume":"14","author":"I Vasim","year":"2022","unstructured":"Vasim I, Majeed CN, DeBoer MD. Intermittent fasting and metabolic health. Nutrients. 2022;14:631. https:\/\/doi.org\/10.3390\/nu14030631.","journal-title":"Nutrients"},{"key":"3185_CR81","doi-asserted-by":"publisher","DOI":"10.31478\/202007b","author":"ME Auld","year":"2020","unstructured":"Auld ME, Allen MP, Hampton C, Montes JH, Sherry C, Mickalide AD, Logan RA, Alvarado-Little W, Parson K. Health literacy and health education in schools: collaboration for action. NAM Perspect. 2020. https:\/\/doi.org\/10.31478\/202007b.","journal-title":"NAM Perspect"},{"key":"3185_CR82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1559827615619159","volume":"12","author":"KI Galaviz","year":"2015","unstructured":"Galaviz KI, Narayan KMV, Lobelo F, Weber MB. Lifestyle and the prevention of type 2 diabetes: a status report. Am J Lifestyle Med. 2015;12:4\u201320. https:\/\/doi.org\/10.1177\/1559827615619159.","journal-title":"Am J Lifestyle Med"},{"key":"3185_CR83","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jfmpc.jfmpc_228_18","volume":"8","author":"SPS Chawla","year":"2019","unstructured":"Chawla SPS, Kaur S, Bharti A, Garg R, Kaur M, Soin D, Ghosh A, Pal R. Impact of health education on knowledge, attitude, practices and glycemic control in type 2 diabetes mellitus. J Family Med Prim Care. 2019;8:261\u20138. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_228_18.","journal-title":"J Family Med Prim Care"},{"issue":"Suppl 1","key":"3185_CR84","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1016\/j.dsx.2016.12.022","volume":"11","author":"H Khalil","year":"2017","unstructured":"Khalil H. Diabetes microvascular complications\u2014a clinical update. Diabetes Metab Syndr. 2017;11(Suppl 1):S133\u20139. https:\/\/doi.org\/10.1016\/j.dsx.2016.12.022.","journal-title":"Diabetes Metab Syndr"},{"key":"3185_CR85","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","unstructured":"UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703\u201313.","journal-title":"BMJ"},{"key":"3185_CR86","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1001288","volume":"363","author":"EY Chew","year":"2010","unstructured":"ACCORD Study Group, ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1001288.","journal-title":"N Engl J Med"},{"key":"3185_CR87","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","volume":"3","author":"B Wang","year":"2015","unstructured":"Wang B, Wang F, Zhang Y, Zhao S-H, Zhao W-J, Yan S-L, Wang Y-G. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:263\u201374. https:\/\/doi.org\/10.1016\/S2213-8587(14)70256-6.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3185_CR88","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/157339911795843168","volume":"7","author":"M Abbate","year":"2011","unstructured":"Abbate M, Cravedi P, Iliev I, Remuzzi G, Ruggenenti P. Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives. Curr Diabetes Rev. 2011;7:190\u2013200. https:\/\/doi.org\/10.2174\/157339911795843168.","journal-title":"Curr Diabetes Rev"},{"key":"3185_CR89","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2174\/1566524014666140128114414","volume":"14","author":"X Zhang","year":"2014","unstructured":"Zhang X, Wang N, Schachat AP, Bao S, Gillies MC. Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema. Curr Mol Med. 2014;14:376\u201384. https:\/\/doi.org\/10.2174\/1566524014666140128114414.","journal-title":"Curr Mol Med"},{"key":"3185_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006763.pub2","author":"RJ Suckling","year":"2010","unstructured":"Suckling RJ, He FJ, Macgregor GA. Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev. 2010. https:\/\/doi.org\/10.1002\/14651858.CD006763.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3185_CR91","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrendo.2013.184","volume":"9","author":"D Fineberg","year":"2013","unstructured":"Fineberg D, Jandeleit-Dahm KAM, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013;9:713\u201323. https:\/\/doi.org\/10.1038\/nrendo.2013.184.","journal-title":"Nat Rev Endocrinol"},{"key":"3185_CR92","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/1744-1609.12010","volume":"11","author":"H Khalil","year":"2013","unstructured":"Khalil H. Painful diabetic neuropathy management. Int J Evid Based Healthc. 2013;11:77\u20139. https:\/\/doi.org\/10.1111\/1744-1609.12010.","journal-title":"Int J Evid Based Healthc"},{"key":"3185_CR93","first-page":"372","volume":"40","author":"K Cohen","year":"2015","unstructured":"Cohen K, Shinkazh N, Frank J, Israel I, Fellner C. Pharmacological treatment of diabetic peripheral neuropathy. P T. 2015;40:372\u201388.","journal-title":"P T"},{"key":"3185_CR94","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.clinthera.2017.02.010","volume":"39","author":"F van Nooten","year":"2017","unstructured":"van Nooten F, Treur M, Pantiri K, Stoker M, Charokopou M. Capsaicin 8% patch versus oral neuropathic pain medications for the treatment of painful diabetic peripheral neuropathy: a systematic literature review and network meta-analysis. Clin Ther. 2017;39:787-803.e18. https:\/\/doi.org\/10.1016\/j.clinthera.2017.02.010.","journal-title":"Clin Ther"},{"key":"3185_CR95","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11892-012-0287-2","volume":"12","author":"V Spallone","year":"2012","unstructured":"Spallone V. Management of painful diabetic neuropathy: guideline guidance or jungle? Curr Diab Rep. 2012;12:403\u201313. https:\/\/doi.org\/10.1007\/s11892-012-0287-2.","journal-title":"Curr Diab Rep"},{"key":"3185_CR96","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/CIRCRESAHA.115.306884","volume":"118","author":"JA Beckman","year":"2016","unstructured":"Beckman JA, Creager MA. Vascular complications of diabetes. Circ Res. 2016;118:1771\u201385. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306884.","journal-title":"Circ Res"},{"key":"3185_CR97","first-page":"189","volume":"5","author":"JT Lu","year":"2004","unstructured":"Lu JT, Creager MA. The relationship of cigarette smoking to peripheral arterial disease. Rev Cardiovasc Med. 2004;5:189\u201393.","journal-title":"Rev Cardiovasc Med"},{"key":"3185_CR98","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1059\/0003-4819-154-11-201106070-00003","volume":"154","author":"D Conen","year":"2011","unstructured":"Conen D, Everett BM, Kurth T, Creager MA, Buring JE, Ridker PM, Pradhan AD. Smoking, smoking cessation and risk of symptomatic peripheral artery disease in women: a prospective study. Ann Intern Med. 2011;154:719\u201326. https:\/\/doi.org\/10.1059\/0003-4819-154-11-201106070-00003.","journal-title":"Ann Intern Med"},{"key":"3185_CR99","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000174066","volume":"19","author":"H Haller","year":"1996","unstructured":"Haller H. Hypertension, the endothelium and the pathogenesis of chronic vascular disease. Kidney Blood Press Res. 1996;19:166\u201371. https:\/\/doi.org\/10.1159\/000174066.","journal-title":"Kidney Blood Press Res"},{"key":"3185_CR100","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/157016106777698388","volume":"4","author":"S Ludwig","year":"2006","unstructured":"Ludwig S, Shen GX. Statins for diabetic cardiovascular complications. Curr Vasc Pharmacol. 2006;4:245\u201351. https:\/\/doi.org\/10.2174\/157016106777698388.","journal-title":"Curr Vasc Pharmacol"},{"issue":"Suppl 2","key":"3185_CR101","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.2337\/dc09-S333","volume":"32","author":"JA Davidson","year":"2009","unstructured":"Davidson JA, Parkin CG. Is hyperglycemia a causal factor in cardiovascular disease? Does proving this relationship really matter? Yes Diabetes Care. 2009;32(Suppl 2):S331-333. https:\/\/doi.org\/10.2337\/dc09-S333.","journal-title":"Yes Diabetes Care"},{"key":"3185_CR102","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023950","volume":"11","author":"S Shore","year":"2022","unstructured":"Shore S, Basu T, Kamdar N, Brady P, Birati E, Hummel SL, Chopra V, Nallamothu BK. Use and out-of-pocket cost of sacubitril-valsartan in patients with heart failure. J Am Heart Assoc. 2022;11: e023950. https:\/\/doi.org\/10.1161\/JAHA.121.023950.","journal-title":"J Am Heart Assoc"},{"key":"3185_CR103","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jsps.2023.04.002","volume":"31","author":"A Matyori","year":"2023","unstructured":"Matyori A, Brown CP, Ali A, Sherbeny F. Statins utilization trends and expenditures in the US before and after the implementation of the 2013 ACC\/AHA guidelines. Saudi Pharm J. 2023;31:795\u2013800. https:\/\/doi.org\/10.1016\/j.jsps.2023.04.002.","journal-title":"Saudi Pharm J"},{"key":"3185_CR104","unstructured":"The role of newer anti-diabetic drugs in cardiovascular disease. https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2018\/05\/22\/16\/59\/http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2farticles%2f2018%2f05%2f22%2f16%2f59%2fthe-role-of-newer-anti-diabetic-drugs-in-cv-disease. Accessed 19 July 2024."},{"key":"3185_CR105","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1056\/NEJMc1712572","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Matthews DR. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:2099. https:\/\/doi.org\/10.1056\/NEJMc1712572.","journal-title":"N Engl J Med"},{"key":"3185_CR106","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603827.","journal-title":"N Engl J Med"},{"key":"3185_CR107","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","volume":"5","author":"S Kalra","year":"2014","unstructured":"Kalra S. Sodium glucose co-transporter-2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology. Diabetes Ther. 2014;5:355\u201366. https:\/\/doi.org\/10.1007\/s13300-014-0089-4.","journal-title":"Diabetes Ther"},{"key":"3185_CR108","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, Brunner-La Rocca H-P, Choi D-J, Chopra V, Chuquiure-Valenzuela E, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385:1451\u201361. https:\/\/doi.org\/10.1056\/NEJMoa2107038.","journal-title":"N Engl J Med"},{"key":"3185_CR109","doi-asserted-by":"publisher","first-page":"1293926","DOI":"10.3389\/fcdhc.2023.1293926","volume":"4","author":"L Ferhatbegovi\u0107","year":"2023","unstructured":"Ferhatbegovi\u0107 L, Mr\u0161i\u0107 D, Maci\u0107-D\u017eankovi\u0107 A. The benefits of GLP1 receptors in cardiovascular diseases. Front Clin Diabetes Healthc. 2023;4:1293926. https:\/\/doi.org\/10.3389\/fcdhc.2023.1293926.","journal-title":"Front Clin Diabetes Healthc"},{"key":"3185_CR110","doi-asserted-by":"publisher","unstructured":"Dhankhar S, Chauhan S, Mehta DK, Nitika, Saini K, Saini M, Das R, Gupta S, Gautam V. Novel targets for potential therapeutic use in diabetes mellitus. Diabetol Metab Syndr. 2023;15:17. https:\/\/doi.org\/10.1186\/s13098-023-00983-5.","DOI":"10.1186\/s13098-023-00983-5"},{"key":"3185_CR111","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","volume":"93","author":"K Chapman","year":"2013","unstructured":"Chapman K, Holmes M, Seckl J. 11\u03b2-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev. 2013;93:1139\u2013206. https:\/\/doi.org\/10.1152\/physrev.00020.2012.","journal-title":"Physiol Rev"},{"key":"3185_CR112","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2144\/02333dd01","volume":"33","author":"C Hug","year":"2002","unstructured":"Hug C, Lodish HF. Diabetes, obesity, and Acrp30\/adiponectin. Biotechniques. 2002;33:654. https:\/\/doi.org\/10.2144\/02333dd01. (656, 658 passim).","journal-title":"Biotechniques"},{"key":"3185_CR113","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941\u20136. https:\/\/doi.org\/10.1038\/90984.","journal-title":"Nat Med"},{"key":"3185_CR114","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.2337\/db15-0274","volume":"64","author":"Z-Y Li","year":"2015","unstructured":"Li Z-Y, Song J, Zheng S-L, Fan M-B, Guan Y-F, Qu Y, Xu J, Wang P, Miao C-Y. Adipocyte Metrnl antagonizes insulin resistance through PPAR\u03b3 signaling. Diabetes. 2015;64:4011\u201322. https:\/\/doi.org\/10.2337\/db15-0274.","journal-title":"Diabetes"},{"key":"3185_CR115","doi-asserted-by":"publisher","first-page":"1098570","DOI":"10.3389\/fimmu.2023.1098570","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Gao Z, Sun T, Zhang S, Yang S, Zheng M, Shen H. Meteorin-like\/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: a comprehensive review of preclinical and clinical studies. Front Immunol. 2023;14:1098570. https:\/\/doi.org\/10.3389\/fimmu.2023.1098570.","journal-title":"Front Immunol"},{"key":"3185_CR116","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/vhrm.s993","volume":"4","author":"F Chiarelli","year":"2008","unstructured":"Chiarelli F, Di Marzio D. Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives. Vasc Health Risk Manag. 2008;4:297\u2013304. https:\/\/doi.org\/10.2147\/vhrm.s993.","journal-title":"Vasc Health Risk Manag"},{"key":"3185_CR117","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","volume":"157","author":"RR Rao","year":"2014","unstructured":"Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, Jedrychowski MP, Ruas JL, Wrann CD, Lo JC, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014;157:1279\u201391. https:\/\/doi.org\/10.1016\/j.cell.2014.03.065.","journal-title":"Cell"},{"key":"3185_CR118","doi-asserted-by":"publisher","first-page":"1136245","DOI":"10.3389\/fendo.2023.1136245","volume":"14","author":"C Garcia-Beltran","year":"2023","unstructured":"Garcia-Beltran C, Navarro-Gascon A, L\u00f3pez-Bermejo A, Quesada-L\u00f3pez T, de Zegher F, Ib\u00e1\u00f1ez L, Villarroya F. Meteorin-like levels are associated with active brown adipose tissue in early infancy. Front Endocrinol (Lausanne). 2023;14:1136245. https:\/\/doi.org\/10.3389\/fendo.2023.1136245.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3185_CR119","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4161\/self.1.3.12643","volume":"1","author":"MS Wong","year":"2010","unstructured":"Wong MS, Hawthorne WJ, Manolios N. Gene therapy in diabetes. Self Nonself. 2010;1:165\u201375. https:\/\/doi.org\/10.4161\/self.1.3.12643.","journal-title":"Self Nonself"},{"key":"3185_CR120","doi-asserted-by":"publisher","first-page":"e46243","DOI":"10.7759\/cureus.46243","volume":"15","author":"A Fatima","year":"2023","unstructured":"Fatima A, Rasool S, Devi S, Talha M, Waqar F, Nasir M, Khan MR, Ibne Ali Jaffari SM, Haider A, Shah SU, et al. Exploring the cardiovascular benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors: expanding horizons beyond diabetes management. Cureus. 2023;15:e46243. https:\/\/doi.org\/10.7759\/cureus.46243.","journal-title":"Cureus"},{"key":"3185_CR121","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cdtm.2020.07.002","volume":"6","author":"F Yang","year":"2020","unstructured":"Yang F, Meng R, Zhu D-L. Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors. Chronic Dis Transl Med. 2020;6:239\u201345. https:\/\/doi.org\/10.1016\/j.cdtm.2020.07.002.","journal-title":"Chronic Dis Transl Med"},{"key":"3185_CR122","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.117.030012","volume":"136","author":"L Yuliya","year":"2017","unstructured":"Yuliya L, Petter B, Udell JA, Lovshin JA, Cherney DZ. Sodium glucose cotransporter-2 inhibition in heart failure: potential mechanisms, clinical applications and summary of clinical trials. Circulation. 2017;136:1643\u201358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030012.","journal-title":"Circulation"},{"key":"3185_CR123","doi-asserted-by":"publisher","first-page":"e45487","DOI":"10.7759\/cureus.45487","volume":"15","author":"P Parab","year":"2023","unstructured":"Parab P, Chaudhary P, Mukhtar S, Moradi A, Kodali A, Okoye C, Klein D, Mohamoud I, Olanisa OO, Hamid P. Role of glucagon-like peptide-1 (GLP-1) receptor agonists in cardiovascular risk management in patients with type 2 diabetes mellitus: a systematic review. Cureus. 2023;15:e45487. https:\/\/doi.org\/10.7759\/cureus.45487.","journal-title":"Cureus"},{"key":"3185_CR124","doi-asserted-by":"publisher","first-page":"1008922","DOI":"10.3389\/fcvm.2022.1008922","volume":"9","author":"L Scisciola","year":"2022","unstructured":"Scisciola L, Cataldo V, Taktaz F, Fontanella RA, Pesapane A, Ghosh P, Franzese M, Puocci A, De Angelis A, Sportiello L, et al. Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: data from basic science and clinical trials. Front Cardiovasc Med. 2022;9:1008922. https:\/\/doi.org\/10.3389\/fcvm.2022.1008922.","journal-title":"Front Cardiovasc Med"},{"key":"3185_CR125","doi-asserted-by":"publisher","first-page":"204201882312223","DOI":"10.1177\/20420188231222367","volume":"15","author":"SH Alharbi","year":"2024","unstructured":"Alharbi SH. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024;15:20420188231222370. https:\/\/doi.org\/10.1177\/20420188231222367.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3185_CR126","doi-asserted-by":"publisher","first-page":"10164","DOI":"10.3390\/ijms241210164","volume":"24","author":"F Piccirillo","year":"2023","unstructured":"Piccirillo F, Mastroberardino S, Nusca A, Frau L, Guarino L, Napoli N, Ussia GP, Grigioni F. Novel antidiabetic agents and their effects on lipid profile: a single shot for several cardiovascular targets. Int J Mol Sci. 2023;24:10164. https:\/\/doi.org\/10.3390\/ijms241210164.","journal-title":"Int J Mol Sci"},{"key":"3185_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.949113","volume":"9","author":"C Chen","year":"2022","unstructured":"Chen C, Yuan S, Zhao X, Qiao M, Li S, He N, Huang L, Lyu J. Metformin protects cardiovascular health in people with diabetes. Front Cardiovasc Med. 2022;9: 949113. https:\/\/doi.org\/10.3389\/fcvm.2022.949113.","journal-title":"Front Cardiovasc Med"},{"issue":"Suppl 1","key":"3185_CR128","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00003495-199958001-00009","volume":"58","author":"NF Wiernsperger","year":"1999","unstructured":"Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs. 1999;58 (Suppl 1):31\u201382. https:\/\/doi.org\/10.2165\/00003495-199958001-00009.","journal-title":"Drugs"},{"key":"3185_CR129","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1111\/jcmm.17519","volume":"26","author":"Y Bu","year":"2022","unstructured":"Bu Y, Peng M, Tang X, Xu X, Wu Y, Chen AF, Yang X. Protective effects of metformin in various cardiovascular diseases: clinical evidence and AMPK-dependent mechanisms. J Cell Mol Med. 2022;26:4886\u2013903. https:\/\/doi.org\/10.1111\/jcmm.17519.","journal-title":"J Cell Mol Med"},{"issue":"19","key":"3185_CR130","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1111\/jcmm.17519","volume":"26","author":"Y Bu","year":"2022","unstructured":"Bu Y, Peng M, Tang X, et al. Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms. J Cell Mol Med. 2022;26(19):4886\u20134903. https:\/\/doi.org\/10.1111\/jcmm.17519.","journal-title":"J Cell Mol Med"},{"key":"3185_CR131","unstructured":"Eggleton JS, Jialal I. Thiazolidinediones. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551656\/."},{"key":"3185_CR132","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/ijms22083850","volume":"22","author":"DJ Medina-Leyte","year":"2021","unstructured":"Medina-Leyte DJ, Zepeda-Garc\u00eda O, Dom\u00ednguez-P\u00e9rez M, Gonz\u00e1lez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22:3850. https:\/\/doi.org\/10.3390\/ijms22083850.","journal-title":"Int J Mol Sci"},{"key":"3185_CR133","unstructured":"Wh T. Do Thiazolidinediones cause heart failure? A critical review. PubMed."},{"key":"3185_CR134","unstructured":"Kasina SVSK, Baradhi KM. Dipeptidyl peptidase IV (DPP IV) inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542331\/."},{"key":"3185_CR135","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4330\/wjc.v13.i10.585","volume":"13","author":"DI Patoulias","year":"2021","unstructured":"Patoulias DI, Boulmpou A, Teperikidis E, Katsimardou A, Siskos F, Doumas M, Papadopoulos CE, Vassilikos V. Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of cardiovascular outcome trials. World J Cardiol. 2021;13:585\u201392. https:\/\/doi.org\/10.4330\/wjc.v13.i10.585.","journal-title":"World J Cardiol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03185-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T08:00:10Z","timestamp":1747468810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03185-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":135,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03185-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alan D Kaye is an Editorial Board member of Advances in Therapy. Alan Kaye was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. All other authors (Kazi Islam, Rahib Islam, Ivan Nguyen, Hassan Malik, Humza Pirzadah, Barsha Shrestha, Isabella B. Lentz and Sahar Shekoohi) declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}